Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Low-dose Naltrexone for atopic dermatitis?

National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/

Dr Armin Schwarzbach - Lyme Disease (2014 Conference) (LDN, low dose naltrexone)

Dr Michael Arata - LDN and small intestinal bacterial overgrowth (SIBO) (2014 Conference) (LDN, low dose naltrexone

Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Dermpath & Clinic: Hailey Hailey disease treated with low-dose naltrexone

Eur J Dermatol
01 October 2021
https://pubmed.ncbi.nlm.nih.gov/34903509/

Cases of patients with Hailey-Hailey disease treated with low-dose naltrexone who achieved resolution of symptoms suggest low-dose naltrexone is an effective novel therapy for Hailey-Hailey disease.

Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis

J Neurosci Res
25 November 2021
https://pubmed.ncbi.nlm.nih.gov/34821408/